Effect of Bone Metastasis on Outcomes in the Cctg Br.34 Phase Ii Randomized Trial of Dual Immune Checkpoint Inhibitor (Ici) Treatment with or Without Chemotherapy in High-Risk, Stage Iva/B Nsclc.

AuthID
 P-00X-E7N
16
Author(s)
Ali, SM
·
Ding, KY
·
Leighl, NB
·
Badillo, FEV
·
Gaudreau, PO
·
Bradbury, PA
·
Goss, GD
·
Shepherd, LE
·
Costa, L
·
Suva, LJ
·
Drabick, JJ
·
Ma, PC
·
Joshi, M
·
Polimera, HV
·
Lipton, A
Tipo de Documento
Abstract
Year published
2022
Publicado
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 40, Número: 16
Indexing
Wos®
Publication Identifiers
Wos: WOS:000863680302254
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service